Prothena Corp PLC (PRTA)
14.44
+0.04
(+0.28%)
USD |
NASDAQ |
Nov 21, 16:00
14.75
+0.31
(+2.15%)
After-Hours: 20:00
Prothena Enterprise Value: 257.74M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 257.74M |
| November 20, 2024 | 255.58M |
| November 19, 2024 | 236.75M |
| November 18, 2024 | 207.69M |
| November 15, 2024 | 234.60M |
| November 14, 2024 | 347.06M |
| November 13, 2024 | 407.86M |
| November 12, 2024 | 414.86M |
| November 11, 2024 | 453.60M |
| November 08, 2024 | 433.15M |
| November 07, 2024 | 421.85M |
| November 06, 2024 | 468.13M |
| November 05, 2024 | 389.03M |
| November 04, 2024 | 366.43M |
| November 01, 2024 | 376.65M |
| October 31, 2024 | 395.49M |
| October 30, 2024 | 453.60M |
| October 29, 2024 | 464.36M |
| October 28, 2024 | 427.23M |
| October 25, 2024 | 304.01M |
| October 24, 2024 | 356.21M |
| October 23, 2024 | 373.42M |
| October 22, 2024 | 371.27M |
| October 21, 2024 | 368.58M |
| October 18, 2024 | 401.40M |
| Date | Value |
|---|---|
| October 17, 2024 | 398.71M |
| October 16, 2024 | 401.94M |
| October 15, 2024 | 391.18M |
| October 14, 2024 | 412.70M |
| October 11, 2024 | 407.32M |
| October 10, 2024 | 383.65M |
| October 09, 2024 | 364.81M |
| October 08, 2024 | 378.81M |
| October 07, 2024 | 373.42M |
| October 04, 2024 | 387.95M |
| October 03, 2024 | 384.72M |
| October 02, 2024 | 378.27M |
| October 01, 2024 | 376.65M |
| September 30, 2024 | 380.96M |
| September 27, 2024 | 514.17M |
| September 26, 2024 | 519.01M |
| September 25, 2024 | 534.07M |
| September 24, 2024 | 620.12M |
| September 23, 2024 | 619.04M |
| September 20, 2024 | 598.07M |
| September 19, 2024 | 600.76M |
| September 18, 2024 | 591.08M |
| September 17, 2024 | 615.82M |
| September 16, 2024 | 613.13M |
| September 13, 2024 | 624.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-74.79M
Minimum
Mar 18 2020
3.460B
Maximum
May 05 2023
1.140B
Average
869.33M
Median
Sep 14 2022
Enterprise Value Benchmarks
| Amarin Corp PLC | -89.82M |
| Jazz Pharmaceuticals PLC | 11.06B |
| Iterum Therapeutics PLC | 31.18M |
| GH Research PLC | 350.47M |
| Mural Oncology PLC | -118.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -59.00M |
| Revenue (Quarterly) | 0.97M |
| Total Expenses (Quarterly) | 67.48M |
| EPS Diluted (Quarterly) | -1.10 |
| Profit Margin (Quarterly) | -6.08K% |
| Earnings Yield | -17.17% |
| Normalized Earnings Yield | -17.17 |